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ABSTRACT: The aim of the present work was to evaluate whether L-cysteine enhances the 
antibiotic susceptibility of extended-spectrum beta-lactamase (ESBL) Escherichia coli strains to 
ciprofloxacin and to identify the role of Reactive oxygen species (ROS) in the antimicrobial activity.  
The combined ef5fect of L-cysteine and ciprofloxacin was investigated by the macrodilution broth 
method and chemiluminescence assay. ESBL 1 and ESBL 2 strains presented a growth inhibition 
when they were incubated with 0.4 or 0.2 mM of cysteine, respectively compared to the control 
without antibiotic. Both strains at sub-inhibitory concentration of ciprofloxacin were combined with 
cysteine, and a clear growth inhibition respect to the control was observed. An increase of 68% in 
ROS occurred respect to the control when ESBL 1 was treated with a combination of ciprofloxacin 
and cysteine, while for ESBL 2 there was a rice of 127 %. The combination of ciprofloxacin with 
cysteine had the capacity to undergo redox cycling and ROS production with subsequent cellular 
injury. 
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1.INTRODUCTION 
The emergence of Escherichia coli being resistant to antibiotics is a problem that affects various 
countries. Organisms expressing extended-spectrum beta-lactamases (ESBL) are widely distributed 
worldwide, although prevalence rates are significantly higher in certain geographical regions [1]. 
ESBLs are in the 2be group of the Karen Bush classification derived from specific mutations of 
genes encoding betalactamases e.g. TEM-1, TEM-2 and SHV-1. These confer resistance to all beta-
lactam antibiotics except cephamycins and carbapenems and may also confer resistance to other 
classes of antibiotics; such as aminoglycosides, quinolones, trimethoprim, sulphonamides, 
tetracyclines and chloramphenicol, due to the plasmids carrying the genes coding for ESBLs. In 
addition, ESBL generally contain other genes of resistance to various antibiotics, thus delimiting 
further the therapeutic options available against infections caused by enterobacteria with ESBL [2-
4]. Quinolone resistance and ESBL production are often associated in Enterobacteriaceae and are 
cross-resistant to quinolones and beta-lactams. Hence, the prescription of one of these categories of 
antibiotics may consequently be selected for bacteria which are resistant to both categories [5]. The 
generation of reactive oxygen species (ROS) is an inevitable aspect of life under aerobic conditions. 
These are continuously produced as side-products of certain metabolic pathways and by some 
specific systems, with oxidative stress investigation related to different applied aspects including 
medicine having become increasingly popular [6]. Our previous results indicated that the antibiotics 
used in clinical treatments such as fluoroquinolones, chloramphenicol, ceftazidime, among others, 
induce oxidative stress in different bacterial species [7-10]. In this sense, we have demonstrated that 
ciprofloxacin increases superoxide anion (O2-) in sensitive strains of Staphylococcus aureus, which 
is accompanied by an evident rise in 8-oxodG, considered to be the major DNA marker of oxidative 
stress [11]. In addition, it was previously reported that bacterial gyrase inhibitors such as synthetic 
quinolone antibiotics promoted the formation of hydroxyl radicals which contributed to cell death 
[12]. Several years ago, it was described that cysteine is bactericidal to or inhibits the growth of a 
variety of microorganisms, including, Salmonella typhimurium. In addition, this amino acid 
undergoes a metal ion-catalyzed autoxidation, leading to hydrogen peroxide production [13]. 
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Cysteine has also been shown to inhibit RNA synthesis as well as branched-chain amino acid 
synthesis in E. coli, and it has been suggested that these metabolic alterations may result in an 
unbalanced growth of this organism. In E. coli, cysteine toxicity has been shown to be due to a 
cysteine-specific inhibition of the branched-chain amino acid synthesis [14]. Taking this background 
into account, our aim of the present study was to evaluate whether cysteine enhances the antibiotic 
susceptibility of E. coli ESBL strains to ciprofloxacin, and to identify more precisely the role of 
ROS in the antimicrobial activity. 
2. MATERIALS AND METHODS 
Drugs 
Chemicals. The L-cysteine and bis-N-methylacridinium nitrate (lucigenin) used were products of 
Sigma Chemical Co., St. Louis, Mo. The antibiotic ciprofloxacin HCl was purchased from Parafarm. 
Bacterial strains and antibiotic susceptibility test. 
Two extended-spectrum beta-lactamase-producing E. coli (ESBL) strains (ESBL 1 and ESBL 2) 
from hospitalized patients were kindly provided by Sanatorio Aconcagua from Córdoba, Argentina. 
Stock cultures were maintained in tryptic soy broth and stored frozen in 10% of glycerol. The 
screening and confirmatory methods to detect the presence of ESBLs were used according to the 
Clinical and Laboratory Standard Institute (CLSI: M100-S20, 2015) [15].  
Evaluation of cysteine toxicity in Escherichia coli ESBL strains. 
To evaluate the potential toxicity of cysteine toward two strains of E. coli (ESBL strain 1 and ESBL 
strain 2), minimal medium M-9 was used. This medium was prepared with the following formula 
per liter of distilled water: 6.8 g Na2HPO4, 3.0 g of KH2 PO4, 1.0 g of NH4Cl, 0.5 g NaCl; final pH 
6.8 ± 0.2 at 25 ° C, and the mixture was sterilized by the method of pressurized steam at 121 °C for 
15 minutes. Aseptically, 20 mL of sterile of 20% glucose and 2 mL of sterile 1 M magnesium sulfate 
were added [13]. Both E. coli suspensions with a final concentration of approximately 1x106 
CFU/mL (colonies forming units per mL) were prepared from overnight cultures in M-9 medium. 
Each suspension was exposed to different concentrations of cysteine (ranging from 0.05 to 1.6 mM) 
by adding an appropriate volume of cysteine stock solution to reach a final volume of 1 mL, which 
was incubated at 37 ºC for 24 h. A control inoculum of each strain (culture prepared in minimal 
medium without cysteine) was also run in parallel. After being incubated overnight at 37°C, the 
turbidity was observed. 
MIC determination 
The MICs of ESBL 1 and ESBL 2 of ciprofloxacin were determined in a minimal medium M-9 by 
using the tube dilution method.  Suspensions of E. coli strains (ESBL 1 and ESBL 2) were prepared 
from overnight cultures and diluted to obtain a final concentration of approximately 5x105 CFU/mL, 
after which ciprofloxacin in the range of 0.083 to 1.33 mM was added. Bacterial growth was 
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observed at 24 h of incubation at 37 °C. 
Checkerboard Assay 
The interaction between cysteine and ciprofloxacin was evaluated by the checkerboard method [16]. 
Bacterial growth inhibition resulting from the interactions was determined by the macrodilution test. 
The concentrations of each tested agent used in the combinations corresponded to serial 2-fold 
dilutions. The concentrations of cysteine were ranged from 0.05 to 0.8 mM in medium M-9. 
Dilutions of ciprofloxacin (0.083 to 1.33 mM) were also prepared in the same manner. An overnight 
culture of each microorganism was diluted to achieve a cell density in the range of 5x105 CFU/mL. 
The fractional inhibitory concentration (FIC) was calculated using the MIC from the checkerboard 
assay and the MIC of each compound alone, obtained in parallel in the same assay, according to the 
following formula: FIC=MIC of antimicrobial agent in combination/MIC of antimicrobial agent 
alone. Then, the synergistic effect was evaluated by calculating the FICindex (FICI) for each 
combination, by adding the individual FIC values. A FICI of 0.5 indicated synergy for the 
combination. When it fell between 0.5 and 1, it was defined as an additive effect, and between 1.0 
and 4.0 it was classified as “no interaction”. Finally, a FICI >4.0 indicated antagonism between the 
components in the combination. 
Determination of ROS by the chemiluminescence (CL) assay. 
Oxidative stress was investigated in a BioOrbit luminometer and the chemiluminescence assay was 
quantified by the light emitted when ROS gave electrons to bis-N-methylacridinium nitrate 
(lucigenin, Sigma). Suspensions of E. coli strains (ESBL 1 and ESBL 2) were prepared from 
overnight cultures in a minimal medium (M-9) and optical densities (OD) were measured at 600 nm 
and diluted to obtain an OD of 0.05. Then, 50 µL of these suspensions were added to 5 mL of M-9 
medium and incubated for 2 h at 37°C to reach the log-phase growth.  Then, 0.1 mL of these 
suspensions were incubated with 0.1 mL of lucigenin (75 μg/mL) and 0.1 mL of phosphate buffer 
saline (PBS, pH 7.4), and immediately following this, 0.1 mL of ciprofloxacin (at concentrations 
corresponding to the MIC), 0.1 mL of cysteine (0.8 mM) or the association of both compounds was 
added. Finally, the reaction was triggered with 0.1 mL of dimethylsulfoxide (DMSO).  Basal 
controls of ROS production were made with bacterial suspension in the absence of antibiotic or 
cysteine. The light emitted by ROS was expressed as relative light units (RLU) at various times in 
seconds, with the subtraction of the background. 
Statistical methods 
Statistical analysis was assessed by the Student’s t-test and p <0.05 was taken as being statistically 
significant. The experiments were repeated at least three times. 
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3. RESULTS AND DISCUSSION 
Evaluation of the association of cysteine with ciprofloxacin in Escherichia coli strains  
The MIC of ciprofloxacin obtained for ESBL 1 was 0.33 mM and 0.165 mM for ESBL 2 in M-9 
medium. Cultures of strains ESBL 1 and ESBL 2 presented a growth inhibition when they were 
incubated with 0.4 mM and 0.2 mM cysteine compared to the control, respectively. 
Synergy studies 
Cysteine plus ciprofloxacin combination exhibited a synergistic effect for the strain ESBL 1 (Table 
1, inset A). A FIC of 0.125 was obtained with ciprofloxacin concentration of 0.66 mM, when 
cysteine was combined with this antibiotic, a value of FICIcys-cip of 0.375 was achieved. In the case 
of ESBL2, a FIC of 0.25 was gained at 0.33 when the concentration of ciprofloxacin was 0.33 mM, 
when combined with cysteine, a value of FICIcys-cip of 0.5 was accomplished (Table 1, inset B). 
Determination of ROS by the chemiluminescence (CL) assay. 
Chemiluminescence assays revealed a higher degree of oxidative stress in the ESBL 2 strain 
compared to ESBL 1. When this latter strain was treated with a combination of ciprofloxacin at 1.39 
mM and 0.8 mM of cysteine, the maximum value of RLU reached was 0.183  0.030, representing 
an increase of 68% respect to the control without antibiotic or cysteine (Figure 1A).  
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Figure 1. ROS generation in E. coli determined by chemiluminescence assay. A. ESBL 1 strain. 
Control (), treated with 1.39 mM ciprofloxacin (), 0.8 mM cysteine (▲), or a combination of 
ciprofloxacin and cysteine (). B. ESBL 2 strain. Control (), treated with 0.69 mM ciprofloxacin 
(), 0.8 mM cysteine (▲), or a combination of ciprofloxacin and cysteine (). 
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While for the ESBL 2 strain, the maximum value of RLU attained was 0.216  0.059, which was an 
increase of 127 % respect to the control (Figure 1B). These results agreed with the level of 
susceptibility of each strain to the antibiotic, since ESBL 1 was more resistant than ESBL 2 and this 
could have been related to less generation of ROS occurring in this strain. The first reports on ESBLs 
in Argentina date back to 1990. Since then, dispersion has been observed between different 
Enterobacteria and other Gram-negative bacilli [17,18] which create a problem for therapy. We have 
previously demonstrated that E. coli can react efficiently in the presence of substances that alter the 
level of ROS and have also applied chemiluminescence in the study of the oxidative alterations 
generated in bacteria by antibiotics, including ceftazidime and ciprofloxacin [7, 19]. The 
relationship between antibiotic action and oxidation in clinical strains was also demonstrated in 
Proteus mirabilis treated with ciprofloxacin by Aiassa et al. [9]. Thus, it was interesting to 
investigate the ability of a combination of ciprofloxacin with cysteine to undergo oxidative stress. 
In this work, we have evaluated the effect of ciprofloxacin against Gram negative bacteria. 
Ciprofloxacin targets the DNA topoisomerases and DNA gyrase [20-21]. The studied strains were 
found to be resistant to the antibiotic. However, association with cysteine increased the susceptibility 
and inhibited bacterial growth. The results obtained by chemiluminescence assays confirmed that 
the growth inhibition of ESBL 1 and ESBL 2 strains exposed to the antibiotic and L-cysteine was 
associated with ROS generation. In cytotoxicity assays, Kartal-Hodzic et al. showed that L-cysteine 
was not toxic to the Caco-2 cells until a concentration of 9.9 mM was reached.  The results of this 
toxicity study are very interesting because it demonstrated that L-cysteine might be able to be used 
in different formulations [22].  Previously, was reported that L-cysteine and L-cystine greatly 
potentiated the bactericidal effect of hydrogen peroxide in E. coli K-12 [23]. Although a 
bacteriostatic or bactericidal effect of cysteine on various microorganisms has been known for a 
long time, the present study is the first report which demonstrates that L-cysteine potentiates the 
bactericidal effect of ciprofloxacin, even in bacteria with important resistance to antibiotics. 
Furthermore, these findings support our hypothesis that targeting the respiratory chain could be a 
strategy to increase the susceptibility to antibiotics of resistant strains.  
4. CONCLUSION 
Summing up, the combination of ciprofloxacin and cysteine has the capacity to undergo redox 
cycling and ROS production with subsequent cellular injury. The results of this work reveal new 
perspectives for increasing the antibiotic effects related to the generation of oxidative stress in 
extended-spectrum beta-lactamase-producing Escherichia coli strains. 
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